Current Oncology Reports

, Volume 5, Issue 2, pp 152–157

Chemoprevention of head and neck cancer

  • Katrina Y. Glover
  • Vali A. Papadimitrakopoulou
Article

DOI: 10.1007/s11912-003-0103-x

Cite this article as:
Glover, K.Y. & Papadimitrakopoulou, V.A. Curr Oncol Rep (2003) 5: 152. doi:10.1007/s11912-003-0103-x

Abstract

Squamous cell carcinoma of the head and neck is the most common epithelial neoplasm of the upper aerodigestive tract and represents a major health concern in the United States and worldwide. Invasive squamous cell carcinoma is the end result of a multiyear, multistep process of accumulation of genetic and phenotypic damage. Chemoprevention is defined as the use of pharmacologic or natural agents that inhibit the development of invasive cancer whether by blocking the DNA damage that initiates carcinogenesis or by arresting or reversing the progression of premalignant cells in which such damage has already occurred. Chemoprevention is widely recognized as an important area of research in head and neck cancer. This article reviews the field of chemoprevention and recent advances in molecular epidemiology and genetics. Current clinical trials are described.

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • Katrina Y. Glover
  • Vali A. Papadimitrakopoulou
    • 1
  1. 1.Department of Thoracic/Head and Neck Medical OncologyUniversity of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations